Opioid-related overdose deaths continue to climb at alarming rates ? greater than 200% since 2000. Emerging adults (individuals aged 18-25 years old) are a key demographic in the opioid epidemic, and especially important to engage in treatment, as they account for increasingly high absolute and relative rates of fatal opioid overdoses. Emerging adulthood is a distinct developmental stage and so these treatment engagement efforts should be developmentally tailored. This application describes a 5-year patient-oriented mentored research and training plan to develop a behavioral intervention focused on engagement of high risk emerging adults to treatment after they present to the emergency department with a nonfatal overdose. The proposed intervention model is based on a motivational intervention to reduce overdose risk by improving self-efficacy in adults who have a history of recent nonmedical use of opioid analgesics. My career goal is to become an independent clinician investigator with an expertise in behavioral intervention development and testing for emerging adults with opioid use disorders.
The specific aims of this application are to 1) quantify the time to addiction treatment or recurrent overdose for emerging adults who experience a nonfatal overdose, 2) use qualitative methods to inform intervention development for emerging adults who experience a nonfatal overdose, and 3) conduct a pilot trial to determine feasibility and logistics of the intervention. My educational objectives are to learn: 1) behavioral intervention development, 2) science of behavior change in emerging adults, and 3) clinical trial design. I have identified a well-respected mentoring team and a supportive environment to help me achieve my goals. The results from this work will position me to submit a R01 grant to conduct a fully-powered efficacy trial of an intervention to reduce overdose risk behaviors and increase treatment engagement among emerging adults with non-fatal overdose.

Public Health Relevance

Opioid use and overdose deaths continue to rise in the United States. Emerging adults (18-25 years) have the highest rates of use and are at high risk of fatal overdose. Characteristics of emerging adulthood (increased risk taking, perceived invincibility, identify exploration, and instability) can be barriers to effective engagement in addiction treatment. The investigations in this career development application will capitalize on presentation to an emergency department with a nonfatal overdose as a ?reachable moment? to engage emerging adults in addiction treatment by developing a developmentally appropriate, behavioral intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23DA044324-03
Application #
9734010
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Aklin, Will
Project Start
2017-07-15
Project End
2022-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Carney, Brittany L; Hadland, Scott E; Bagley, Sarah M (2018) Medication Treatment of Adolescent Opioid Use Disorder in Primary Care. Pediatr Rev 39:43-45
Hadland, Scott E; Bagley, Sarah M; Rodean, Jonathan et al. (2018) Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder. JAMA Pediatr 172:1029-1037
Bagley, Sarah M; Cheng, Debbie M; Winter, Michael et al. (2018) Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug Alcohol Depend 192:245-249